^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Endometrial Cancer |
| Drug: | paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) + ifosfamide (Bifunctional alkylating agent) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Endometrial carcinoma: Other recommended regimens…ifosfamide/paclitaxel (for carcinosarcoma)
